Yale Law School Hosts Interdisciplinary Conference on Cancer Policy, Politics, and Law

Left to right: Norman Sharpless, MD, Director, National Cancer Institute; Otis Brawley, MD, Chief Medical Officer, American Cancer Society; and Roy Herbst, MD, PhD, Yale Cancer Center. All photos courtesy of Yale Cancer Center.

Drug Development and the Cost of Researching and Treating Cancer Panel: Back row, left to right: Peter Bach, MD, MAPP, Memorial Sloan Kettering; Levi Garraway, MD, PhD, Eli Lilly; Jeffrey Schwartz, MBA, Bain Capital Life Sciences; James Stansel, JD, PhRMA. Bottom row, left to right: Amy Kapczynski, JD, Yale Law School; Ellen Sigal, PhD, Friends of Cancer Research; Charles Fuchs, MD, MPH, Yale Cancer Center/Smilow Cancer Hospital; Gideon Blumenthal, MD, U.S. Food and Drug Administration (FDA).

Is the Federal Government a Productive Partner in Cancer Policy Panel? Back row, left to right: Richard Schilsky, MD, FASCO, American Society of Clinical Oncology; Peggy Hamburg, MD, Former Commissioner of the FDA (2009–2015); Robert Bazell, PhD, Yale University. Bottom row, left to right: Erik Fatemi, Cornerstone Government Affairs; Patricia LoRusso, DO, Yale Cancer Center; Nancy Goodman, JD, MPP, Kids v Cancer; Harold Varmus, MD, Weill Cornell Medical College.

Cancer, Health Justice, and Disparities Panel: Back row, left to right: Eugene Rusyn, JD, Yale Law School; Cary Gross, MD, Yale School of Medicine; Deborah Schrag, MD, MPH, Dana- Farber Cancer Institute; Blase Polite, MD, University of Chicago Medical Center. Bottom row, left to right: Lindsay Wiley, JD, MPH, American University Washington College of Law; Dayna Bowen Matthew, JD, University of Virginia School of Law; Otis Brawley, MD, American Cancer Society.